大孔球形纤维素载体固定化单宁的制备及其对蛋白质的吸附性能

以自制大孔球形纤维素为载体,利用双环氧试剂1,4-丁二醇二甘油醚引入手臂和环氧基,以单宁酸为配基,制得大孔球形纤维素载体固定化单宁(IMTSC).分别对环氧活化、配基偶联的实验条件进行了考察.环氧活化最适条件为:氢氧化钠溶液浓度0.5mol/L,BDDE用量为2.0ml/g(SC),活化温度25℃,活化时间7h.环氧基密度可达到0.17mmol/g(OSC).配基偶联最适条件为:单宁酸溶液最佳浓度5%,硼氢化钠溶液用量为1.0mL.对固定化单宁吸附蛋白质的性能进行了研究.IMTSC对蛋白质的吸附受缓冲液pH、溶液中的盐浓度、乙醇浓度及反应时间的影响,静态吸附量达到200mg/g干基.     

混合模式色谱配基密度对抗体吸附分离性能的影响

作为蛋白A色谱的重要替代技术,混合模式色谱(mixed-mode chromatography,MMC)具有稳定、廉价和选择性好等优势。本文考察了以Sepharose Fast Flow为基质、4-(咪唑-1-基)苯胺(AN)为配基的新型色谱介质AN SepFF中配基密度对抗体吸附行为和分离性能的影响。研究结果表明,AN SepFF色谱介质在抗体吸附中具有21.2mmol/L的临界配基密度。在临界配基密度以上,抗体在色谱介质上具有较高的吸附容量和很低的解离常数并展现了相当程度的盐耐受性。动态吸附结果进一步表明,抗体的色谱介质中具有与商品化介质相当的动态吸附容量。抗体纯化的结果也表明,在临界配基浓度以上AN SepFF色谱表现出较好的纯化抗体的能力,其抗体产品纯度高于目前商品化的色谱介质;配基密度为55mmol/L时,AN SepFF色谱纯化抗体的收率达到91.9%。由此,AN SepFF色谱介质展现了巨大的应用前景。     

肽配基纳米亲和载体定向固定化抗体

抗体经常被固定在某一固相载体表面用于免疫检测分析,但通常得到的是随机固定化的抗体,因而会影响抗体的活性。本文开发了一种新型的亲和载体用于抗体的定向固定化。即将与抗体IgG的Fc片段具有亲和作用的肽配基偶联于pGMA纳米球上,制备亲和载体用于吸附抗体实现抗体的定向固定化。首先利用乳液聚合法制备了粒径为110nm的pGMA纳米球,再以EDMA为交联剂并且在纳米球表面氨基化,最后将与抗体IgG的Fc片段具有亲和作用的肽配基HWRGWV偶联于纳米球表面,制备得到肽配基纳米球亲和载体。然后,考察了亲和载体对猪IgG的吸附行为。进一步,利用等温滴定微量量热仪研究了该纳米球亲和载体与IgG之间的相互作用热力学。结果表明,肽配基亲和载体对IgG的特异性吸附作用明显高于肽配基修饰前的载体。亲和载体与IgG的亲和作用主要贡献是疏水相互作用;而IgG与氨化纳米球载体的吸附作用则主要通过静电作用和氢键作用。所制得的纳米球亲和载体可用于进一步开发高效率、高灵敏度的临床免疫检测方法。     

亲和吸附剂对细菌内毒素吸附性能的研究

制备了以球形纤维素为载体、8种氨基酸和1种聚赖氨酸为配基的吸附剂,对质量浓度为100.0pg/mL的内毒素水溶液进行了吸附研究,绘制了吸附等温线,并初步探讨了吸附机理.结果表明,精氨酸和赖氨酸配基具有良好的吸附能力,在1.5mL100.0pg/mL内毒素溶液中吸附量分别达到182.0和160.0pg/mL;吸附等温线显示,以赖氨酸为配基的吸附剂其吸附量随溶液内毒素浓度增加而线性增加,符合Langmuir吸附方程,吸附能力强,具有一定的临床应用前景.     

ssDNA-碳化树脂类风显关H免疫吸附剂性能研究

研究了以火棉胶作为包埋材料将DNA配基固定于碳化树脂表面制备的类风湿关节炎免疫吸附剂的吸附性能,静态吸附条件下,当ssDNA的固定量在0.4mg/mL树脂时吸附性能最佳,对3种类风湿因子(RF)的最佳饱和吸附量分别为IgMRF:2458IU/mL、IgGRF:2877IU/mL、IgARF:1100IU/mL.吸附120分钟后达到吸附平衡,对血浆中白蛋白及总蛋白的清除率分别低于8%和6%,表现出较好的吸附选择性.吸附剂经毒理实验证明,使用安全性较高.对活犬进行体外血液灌流实验表明该吸附剂具有良好的血液相容性.     

高性能Pt/La-Ba-Al_2O_3/H-ZSM-5氢燃料汽车尾气处理催化剂

采用胶溶法制备了La-Ba-Al2O3(LBA)材料,以此为载体采用浸渍法制备了两种整体式催化剂Pt/LBA和Pt/LBA/H-ZSM-5,并评价了它们去除NO的性能.采用N2吸附-脱附和X射线衍射对载体材料进行了表征.结果表明,所制备的LBA仅有γ-Al2O3晶相存在,比表面积和孔容分别为144 m2/g和0.45 ml/g,具有较好的抗高温老化性能.在106～356 ℃间,催化剂Pt/LBA/H-ZSM-5上NO转化率很高,在153℃时达到最高为98.8%,此时N2选择性为81.3%.该催化剂有很大的潜在应用价值.     

壳聚糖亲和磁性毫微粒的制备及其对蛋白质的吸附性能研究

以壳聚糖为包裹材料包埋自制的磁流体 ,制备了具有核 壳结构的磁性毫微粒 ,并偶联色素配基CibacronBlue 3GA(偶联量 1 4 .5μmol/mL)得到了一种新型亲和磁性毫微粒 .结果表明 ,所得亲和磁性微球具有较窄的粒径分布、形状规整 .以牛血清白蛋白 (BSA)和溶菌酶 (Lys)为目标蛋白 ,考察了该亲和磁性毫微粒的吸附性能 ,发现其对BSA和Lys的吸附量分别为 4和 2 8mg/g,吸附行为满足Langmuir吸附等温式 ,且对时间依赖性小而对溶液离子强度敏感 .     

一种新型低密度脂蛋白吸附剂的制备

研究表明,人体血浆中低密度脂蛋白(LDL)的含量过高会引起动脉硬化,进而诱发各种心脑血管疾病^[1].近年来,采用血液净化吸附剂去除LDL受到了广泛的关注^[2～10].目前临床上使用的吸附剂主要有固载LDL抗体的琼脂糖吸附剂及固载肝素或磺化葡聚糖的纤维素吸附剂,它们虽有较好的吸附效果,但由于存在配基昂贵、吸附剂成本高及机械强度差等问题,这些吸附剂的应用受到了很大的限制.本文以具有良好机械强度和血液相容性的聚乙烯醇(PVA)大孔珠状树脂为载体,以廉价易得的吲哚-3-乙酸(IAA)为配基,分别以不同长度的多胺为悬臂,制备了一种新型LDL吸附剂,并初步考察了其对LDL的吸附性能.     

IgA肾病免疫吸附剂的研究(Ⅱ)

通过1,4-丁二醇-二缩水甘油醚法活化琼脂糖载体,既起到了活化载体的作用,同时又由于该活化剂分子是长链结构而给载体提供了一定长度的手臂,有利于人免疫球蛋白G(IgG)大分子配基与载体的连接,用该方法制成的免疫吸附剂对高IgA肾病病人血清中IgA进行了吸附研究.通过体外实验条件的优化发现,最高可吸附60%的IgA,同CDI法比较(吸附率可达35%左右),该吸附剂具有较高的吸附效率.     

IgG配基对肿瘤坏死因子α的吸附机制研究

以球形琼脂凝胶为载体,键连免疫球蛋白IgG配基,通过化学修饰等方法,研究了IgG与TNFα的亲和作用机制,进而推测出吸附作用位点.结果显示,IgG分子的氨基、羧基及色氨酸残基中的吲哚基可能影响吸附作用;IgG配基连接手臂可以提高吸附性能,在3000U/mLTNFα血浆中,采用己二胺手臂吸附量可达7084.68U/mL.鉴于IgG配基的高效特异性,研究结果不仅具有一定的理论意义,也有较强的临床应用前景     

Computer Aided Study of Mechanism of Immunoadsorbent for Myasthenia Gravis

Myasthenia Gravis (MG) is an organ specific autoimmune disease mediated by autoantibodies (AChR Ab) against the acetylcholine receptor (AChR). Literature reported that the AChR Ab can be removed by absorbent linked with tryotophan.It was studied in detail in our lab. With the aid of computer, we docked some ligandsinto AChR Ab, and the results fromscores of docking under different generations showed that therewas no specific binding between tryptophan and scFv fragment just as the binding between antigen-antibody. The interaction between Trp and immunoglobulin was a broad-spectntm binding.     

Increased transport of theophylline into gastrointestinal lumen and gastrointestinal dialysis by activated charcoal in rats with hepatic cirrhosis

The characteristics of exsorption and/or excretion of theophylline into the small intestinal lumen in rats with hepatic cirrhosis (HC rats) induced by carbon tetrachloride were investigated by an in situ single-pass perfusion technique. The serum concentrations of theophylline after i.v. administration of aminophylline (10 mg/kg) in the HC rats were significantly higher than those in normal rats during the experimental period. Moreover, the exsorption of theophylline from blood into the intestinal lumen was significantly increased in the HC rats compared with the normal rats. Treatments with oral activated charcoal reduced the serum theophylline levels in the HC rats. Consequently, gastrointestinal dialysis by oral administration of activated charcoal may be a useful method to remove poisonous drugs from the blood in patients with hepatic failure (including cirrhosis), which decreases the systemic clearance.     

Chemometric resolution of fully overlapped CE peaks: Quantitation of carbamazepine in human serum in the presence of several interferences

Drug monitoring in serum samples was performed using second‐order data generated by CE‐DAD, processed with a suitable chemometric strategy. Carbamazepine could be accurately quantitated in the presence of its main metabolite (carbamazepine epoxide), other therapeutic drugs (lamotrigine, phenobarbital, phenytoin, phenylephrine, ibuprofen, acetaminophen, theophylline, caffeine, acetyl salicylic acid), and additional serum endogenous components. The analytical strategy consisted of the following steps: (i) serum sample clean‐up to remove matrix interferences, (ii) data pre‐processing, in order to reduce the background and to correct for electrophoretic time shifts, and (iii) resolution of fully overlapped CE peaks (corresponding to carbamazepine, its metabolite, lamotrigine and unexpected serum components) by the well‐known multivariate curve resolution‐alternating least squares algorithm, which extracts quantitative information that can be uniquely ascribed to the analyte of interest. The analyte concentration in serum samples ranged from 2.00 to 8.00 mg/L. Mean recoveries were 102.6% (s=7.7) for binary samples, and 94.8% (s=13.5) for spiked serum samples, while CV (%)=4.0 was computed for five replicate, indicative of the acceptable accuracy and precision of the proposed method.     

寡肽吸附剂的制备及吸附机理

为清除尿毒症患者血清中分离出的八肽VVRGCTWW(V8), 制备了不同间隔臂长含苯环的吸附剂Phenc. 吸附实验结果显示, 吸附剂Phe3c具有非常好的吸附能力. 采用NMR和分子模拟技术对吸附剂的模型体系的吸附机理进行了研究. 结果显示, 配体中的苯环可与八肽形成π-π堆积, 而且间隔臂的增长可以克服空间位阻效应, 有效增加配体与V8的作用几率, 进而增强吸附剂与八肽的相互作用. 研究结果表明, 采用合理的分子模型及分子对接方法, 不仅可以合理解释吸附剂的吸附机理, 而且可用于吸附剂的虚拟筛选.     

Determination of selenium in blood serum by inductively coupled plasma atomic emission spectrometry with pneumatic nebulization

The possibility of determining selenium in blood serum using inductively coupled plasma emission spectrometry with conventional pneumatic nebulization was studied. A high-resolution spectrometer (SBW=6 pm) with laterally viewed ICP was employed. Analysis with conventional pneumatic nebulization could overcome laborious and demanding digestion, which is necessary for hydride generation. A pressure digestion with nitric acid at 160 degrees C was sufficient to decrease the carbon content in the serum sample to 5%-10% of its original value. Spectral interference of the CN band was observed and mathematically corrected. It was found that the carbon-induced selenium line emission enhancement occurred even under ICP optimized conditions. A method of determination was developed and applied to the analysis of blood serum. True limit of detection in real samples is 0.01-0.02 mg/L and the limit of quantification (RSD 10%) is 0.03-0.07 mg/L using Se I 196.090 nm line at an integration time of 10-2 s. The method was tested by analysis of porcine blood serum and the serum reference material Seronorm MI 0181.     

Studies on Intake and Body Fluid Concentrations of Thorium for Subjects Working and Living in Thorium Rich Environment

The blood serum is the fluid medium through which most of the minerals are absorbed into the human body and get metabolized. The concentrations of Th in blood serum is in equilibrium with the content of Th in human body and therefore could reflect its content in the body. The daily intake (ingestion and inhalation) and the corresponding concentration of Th in blood serum of a group of subjects living in the high-background (monazite) area of Kerala State were measured and compared with the daily intake and corresponding blood serum concentrations of Th in three other groups of subjects namely: (1) those living in normal background area, (2) administrative staff working in Thorium Plant but not directly exposed to Th and its compounds, and (3) the occupational workers from Thorium Plant working for a time period in the range15–30 years. The Th concentration in the blood serum of subjects from high background area were found to be only marginally higher in comparison to the similar data from normalbackground area, which indicated that internal exposure due to Th to the subjects living in high background is quite low.     

Toward ab initio refinement of protein X-ray crystal structures: interpreting and correlating structural fluctuations

The refinement of protein crystal structures currently involves the use of empirical restraints and force fields that are known to work well in many situations but nevertheless yield structural models with some features that are inconsistent with detailed chemical analysis and therefore warrant further improvement. Ab initio electronic structure computational methods have now advanced to the point at which they can deliver reliable results for macromolecules in realistic times using linear-scaling algorithms. The replacement of empirical force fields with ab initio methods in a final refinement stage could allow new structural features to be identified in complex structures, reduce errors and remove computational bias from structural models. In contrast to empirical approaches, ab initio refinements can only be performed on models that obey basic qualitative chemical rules, imposing constraints on the parameter space of existing refinements, and this in turn inhibits the inclusion of unlikely structural features. Here, we focus on methods for determining an appropriate ensemble of initial structural models for an ab initio X-ray refinement, modeling as an example the high-resolution single-crystal X-ray diffraction data reported for the structure of lysozyme (PDB entry “2VB1”). The AMBER force field is used in a Monte Carlo calculation to determine an ensemble of 8 structures that together embody all of the partial atomic occupancies noted in the original refinement, correlating these variations into a set of feasible chemical structures while simultaneously retaining consistency with the X-ray diffraction data. Subsequent analysis of these results strongly suggests that the occupancies in the empirically refined model are inconsistent with protein energetic considerations, thus depicting the 2VB1 structure as a deep-lying minimum in its optimized parameter space that actually embodies chemically unreasonable features. Indeed, density-functional theory calculations for one specific nitrate ion with an occupancy of 62% indicate that water replaces this ion 38% of the time, a result confirmed by subsequent crystallographic analysis. It is foreseeable that any subsequent ab initio refinement of the whole structure would need to locate a globally improved structure involving significant changes to 2VB1 which correct these identified local structural inconsistencies.     

Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS

Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) is the precursor of Delta9-tetrahydrocannabinol (Delta9-THC) in hemp plants. During smoking, the non-psychoactive Delta9-THCA-A is converted to Delta9-THC, the main psychoactive component of marihuana and hashish. Although the decarboxylation of Delta9-THCA-A to Delta9-THC was assumed to be complete--which means that no Delta9-THCA-A should be detectable in urine and blood serum of cannabis consumers--we found Delta9-THCA-A in the urine and blood serum samples collected from police controls of drivers suspected for driving under the influence of drugs (DUID). For LC-MS/MS analysis, urine and blood serum samples were prepared by solid-phase extraction. Analysis was performed with a phenylhexyl column using gradient elution with acetonitrile. For detection of Delta9-THCA-A, the mass spectrometer (MS) (SCIEX API 365 triple-quadrupole MS with TurboIonSpray source) was operated in the multiple reaction monitoring (MRM) mode using the following transitions: m/z357 --> 313, m/z357 --> 245 and m/z357 --> 191. Delta9-THCA-A could be detected in the urine and blood serum samples of several cannabis consumers in concentrations of up to 10.8 ng/ml in urine and 14.8 ng/ml in serum. The concentration of Delta9-THCA-A was below the Delta9-THC concentration in most serum samples, resulting in molar ratios of Delta9-THCA-A/Delta9-THC of approximately 5.0-18.6%. Only in one case, where a short elapsed time between the last intake and blood sampling is assumed, the molar ratio was 18.6% in the serum. This indicates differences in elimination kinetics, which need to be investigated in detail.     

Determination of cefotaxime and desacetylcefotaxime in plasma and urine by high-performance liquid chromatography

A high-performance liquid chromatographic method is described for the analysis of the anti-bacterial agent cefotaxime and desacetylcefotaxime in physiological fluids. Plasma or serum samples were mixed with chloroform--acetone to remove proteins and most lipid material. The aqueous phase was then freeze-dried, reconstituted in mobile phase and chromatographed on a reversed-phase column using UV detection at 262 nm. Urine was analysed directly after centrifugation to remove particulate matter. The detection limit was 0.5--1.0 micrograms/ml for serum and 5 micrograms/ml for urine. The method has been applied to the analyses of cefotaxime and desacetylcefotaxime in plasma, serum, urine, cerebrospinal fluid, saliva, and pus from infected wound secretions. Two additional metabolites, which are lactones in which the beta-lactam ring has been opened, could be separated by this method.     

Isolation of an antiidiotypic antibody with acetylcholine-receptor-like binding properties from myasthenia gravis patients

The network theory predicts that a subpopulation within the antiidiotypic (anti-Id) antibody response will be the internal image of the priming stimulus. In myasthenia gravis, a portion of the anti-acetylcholine-receptor (anti-AChR) antibody repertoire is directed against the ligand-binding site. These antibodies would be expected to elicit an «anti-idiotypeå which is the internal image of the receptor-binding site and hence may also bind cholinergic ligands. We have utilized this theoretical specificity to isolate anti-Id antibodies with AChR-like ligand-binding properties from the serum of 4 myasthenia gravis patients using a choline affinity column. Affinity-purified antibodies from one patient were characterized and found to exhibit binding properties similar to the AChR for various cholinergic ligands.